Determination of residual T- and B-cell content after immunomagnetic depletion: proposal for flow cytometric analysis and results from 103 separations

BackgroundT- and B-cell depletion of apheresis products is an attractive alternative to standard stem cell enrichment in haplo-identical transplantation. Thorough T- and B-cell depletion is necessary for prevention of acute GvHD and T-cell depletion-associated lymphoproliferative disorders. However, the large number of non-T and -B cells in the graft requires special protocols for the determination of extremely low frequencies of residual T cells.MethodsApheresis products from healthy donors were T- and B-cell depleted by the CliniMACS™ system using CD3 and CD19 Ab reagents and the LS tubing set. The recovery of cells and degree of depletion were determined. A four-color multigating strategy was used for enumeration of residual T and B cellsResultsOne-hundred and three separations were performed, with a mean cell recovery of 38 ± 12%, CD34 recovery of 61 ± 16% and CD56 recovery of 63 ± 33%. T and B cells were depleted by log 4.15 ± 0.46 and log 3.64 ± 0.63, respectively. Four-color multigating flow cytometry allowed the detection of single T cells.DiscussionCombined T- and B-cell depletion is a feasible method for obtaining stem cell grafts with acceptable stem cell recovery, profound T- and B-cell depletion and a very high amount of NK cells and monocytes. However, analysis of residual T cells is challenging and requires special protocols.